Crossingbridge Advisors, LLC Vaxxinity, Inc. Transaction History

Crossingbridge Advisors, LLC

  • $190 Billion
  • Q1 2025

A detailed history of Crossingbridge Advisors, LLC transactions in Vaxxinity, Inc. stock. As of the latest transaction made, Crossingbridge Advisors, LLC holds 1,418 shares of VAXX stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,418
Holding current value
$0
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
BUY
$0.0 - $0.05 $0 - $70
1,418 New
1,418 $1.42 Million

Others Institutions Holding VAXX

# of Institutions
3
Shares Held
199K
Call Options Held
0
Put Options Held
0
View Full List

About Vaxxinity, Inc.

VAXX Quotes by TradingView
  • Ticker VAXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 112,150,000
  • Description
  • Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...
More about VAXX
Track This Portfolio

Track Crossingbridge Advisors, LLC Portfolio

Follow Crossingbridge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossingbridge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crossingbridge Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email